Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 6.

Journal Article

Broeckelmann, P. J., Zagadailov, E. A., Corman, S., Hagan, M., Chirikov, V., Johnson, C., Macahilig, C. and Dalal, M. R. (2016). BRENTUXIMAB VEDOTIN (BV) IN PATIENTS WHO ARE INELIGIBLE FOR AUTOLOGOUS STEM CELL TRANSPLANT (ASCT) WITH RELAPSED OR REFRACTORY HODGKIN LYMPHOMA (RRHL): A UK AND GERMANY RETROSPECTIVE STUDY. Haematologica, 101. S. 98 - 99. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078

Broeckelmann, P. J., Zagadailov, E. A., Corman, S., Hagan, M., Chirikov, V., Johnson, C., Macahilig, C., Seal, B., Dalal, M. R. and Illidge, T. (2016). BRENTUXIMAB VEDOTIN IN PATIENTS WHO ARE INELIGIBLE FOR AUTOLOGOUS STEM CELL TRANSPLANT WITH RELAPSED OR REFRACTORY HODGKIN LYMPHOMA: A UNITED KINGDOM AND GERMANY RETROSPECTIVE STUDY. Haematologica, 101. S. 50 - 52. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078

Zagadailov, E. A., Corman, S., Hagan, M., Chirikov, V., Johnson, C., Macahilig, C., Dalal, M. R. and Broeckelmann, P. J. (2016). REAL-WORLD EFFECTIVENESS OF BRENTUXIMAB VEDOTIN (BV) VS OTHER TREATMENTS IN PATIENTS WITH RELAPSED/REFRACTORY HODGKIN LYMPHOMA (RRHL) POST AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT). Haematologica, 101. S. 98 - 100. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078

Zagadailov, E. A., Corman, S., Hagan, M., Chirikov, V., Johnson, C., Macahilig, C., Dalal, M. R. and Broeckelmann, P. J. (2016). RISK FACTORS (RF) FOR RELAPSE IN PATIENTS WITH RELAPSED OR REFRACTORY HODGKIN LYMPHOMA (RRHL) AFTER AUTOLOGOUS STEM CELL TRANSPLANT (ASCT): A REAL-WORLD ANALYSIS IN GERMANY AND THE UNITED KINGDOM (UK). Haematologica, 101. S. 98 - 99. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078

Zagadailov, E. A., Corman, S., Hagan, M., Chirikov, V., Johnson, C., Macahilig, C., Sea, B., Dalal, M. R., Broeckelmann, P. J. and Illidge, T. (2016). REAL-WORLD EFFECTIVENESS OF BRENTUXIMAB VEDOTIN VS OTHER TREATMENTS IN PATIENTS WITH RELAPSED/REFRACTORY HODGKIN LYMPHOMA POST AUTOLOGOUS STEM-CELL TRANSPLANTATION. Haematologica, 101. S. 51 - 52. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078

Zagadailov, E. A., Corman, S., Hagan, M., Chirikov, V., Johnson, C., Macahilig, C., Seal, B., Dalal, M. R., Illidge, T. and Broeckelmann, P. J. (2016). RISK FACTORS FOR RELAPSE IN PATIENTS WITH RELAPSED OR REFRACTORY HODGKIN LYMPHOMA AFTER AUTOLOGOUS STEM CELL TRANSPLANT: A REAL-WORLD ANALYSIS IN GERMANY AND THE UNITED KINGDOM. Haematologica, 101. S. 51 - 53. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078

This list was generated on Tue Mar 2 05:49:20 2021 CET.